Prevalence of Use of Nonglycemic Medications Among Commercially Insured Adults Age ≥20 Years With Type 1 Diabetes, by Age, U.S., 2019
| MEDICATION CLASS* | AGE (YEARS) | |||
|---|---|---|---|---|
| TOTAL | 20–44 | 45–64 | ≥65 | |
| Mean (Standard Error) | ||||
| Total nonglycemic medications† | 2.7 (0.1) | 1.9 (0.2) | 3.8 (0.2) | 4.8 (0.5) |
| Percent (Standard Error) | ||||
| Any antihypertensive medication | 40.7 (0.3) | 24.8 (0.3) | 60.4 (0.5) | 78.5 (0.9) |
| Diuretics | 6.7 (0.2) | 2.9 (0.1) | 10.0 (0.4) | 20.6 (0.9) |
| Angiotensin receptor blockers (ARBs) | 8.0 (0.1) | 3.4 (0.2) | 13.4 (0.4) | 20.7 (0.9) |
| Calcium channel blockers | 5.8 (0.1) | 1.7 (0.1) | 8.9 (0.3) | 22.3 (0.9) |
| Beta blockers | 12.5 (0.2) | 7.1 (0.2) | 17.6 (0.5) | 31.2 (1.0) |
| ACE inhibitors | 21.9 (0.3) | 13.5 (0.2) | 33.3 (0.5) | 38.9 (1.1) |
| Other antihypertensive medications | 7.6 (0.1) | 3.4 (0.1) | 11.6 (0.3) | 21.7 (0.9) |
| Any lipid-lowering medication | 36.2 (0.3) | 17.4 (0.3) | 61.4 (0.5) | 73.5 (1.0) |
| Statins | 35.2 (0.3) | 17.0 (0.3) | 59.7 (0.5) | 72.0 (1.0) |
| Other medication classes | ||||
| Central nervous system agents | 35.2 (0.3) | 31.5 (0.3) | 40.2 (0.5) | 42.9 (1.1) |
| Psychotherapeutics | 21.0 (0.3) | 17.8 (0.3) | 25.9 (0.5) | 24.9 (0.9) |
| Antidepressants | 20.6 (0.2) | 17.5 (0.3) | 25.5 (0.5) | 24.2 (0.9) |
| Respiratory agents | 18.7 (0.2) | 16.7 (0.3) | 21.9 (0.4) | 20.7 (0.9) |
| Gastrointestinal agents | 11.0 (0.2) | 6.1 (0.2) | 16.3 (0.4) | 25.3 (0.9) |
| Hormones | 33.9 (0.3) | 29.9 (0.3) | 39.2 (0.5) | 42.6 (1.1) |
Adults with type 1 diabetes are defined as having at least one type 1 diabetes ICD10 code (E10), no type 2 diabetes ICD10 code (E11) and an insulin prescription. Persons insured through Medicare or Medicaid and persons who are uninsured are not represented in these data. ACE, angiotensin-converting enzyme; ICD10, International Classification of Diseases, Tenth Revision.
A detailed list of medications included in each category is available in Appendix Table A1.
Medications used to treat conditions other than hyperglycemia
SOURCE: Optum Clinformatics Data Mart 2019
From: Medication Use and Self-Care Practices in Persons With Diabetes
Diabetes in America is in the public domain of the United States. You may use the work without restriction in the United States.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.